rumor
    rumor
    • Screeners
    • Heatmaps
    • Charts
    • News
    • Documentation
    • Pricing
    • FAQ
    You're viewing limited data.
    Log inSign up

    Sign up

    24 hours of full access, free. No credit card.

    Log inPricing
    1 asset

    Market news

    TypeAll
    SortNewest
    Assets
    TBPH
    Type
    TypeAll
    All
    Sort
    SortNewest
    Newest

    Filter by asset

      Zymeworks Appoints Suzanne Monahan as Senior Vice President, Commercial and General Manager, Theravance Biopharma
      Oct 19Yahoo FinanceTBPH
      Zymeworks Completes Theravance Deal, Adds YUPELRI Cash Flow and Raises 2026 Outlook
      Oct 2Yahoo FinanceTBPHZYME
      Zymeworks Updates Annual Financial Targets After Finalizing Theravance Biopharma Deal - Zymeworks (NASDAQ

      Zymeworks completes its Theravance Biopharma acquisition, boosts 2026 revenue guidance, and gains recurring revenue from YUPELRI sales.

      Sep 28BenzingaTBPHZYME
      Zymeworks Inc. (ZYME) Theravance Biopharma, Inc. - M&A Call - Slideshow (NASDAQ:ZYME) 2026-09-28
      Sep 28Seeking AlphaTBPHZYME
      Zymeworks Completes Acquisition of Theravance Biopharma; Updates 2026 Guidance

      Zymeworks (ZYME) said Monday it has completed its acquisition of Theravance Biopharma, adding Yupelr

      Sep 28Yahoo FinanceTBPHZYME
      Zymeworks Announces Updated 2026 Financial Guidance and Final Transaction Details Following Theravance Biopharma Acquisition

      Acquisition diversifies durable cash flows and advances Zymeworks’ strategy to build a productive R&D company with a growing portfolio of revenue-generating assetsYUPELRI® expected to contribute immediately accretive revenue and cash flow to Zymeworks with base case mid-teens IRRZymeworks to retain existing commercial organization supporting YUPELRI hospital promotionThe Company expects total revenue, including collaboration revenue from YUPELRI, for 2026 to be between $278 million and $292 mill

      Sep 28Yahoo FinanceTBPHZYME
      Zymeworks completes acquisition of Theravance Biopharma
      Sep 23Investing.comTBPH
      Theravance Biopharma shareholders approve merger with Zymeworks
      Sep 18Investing.comTBPHZYME
      Zymeworks' Theravance Deal Is A Breath Of Fresh Cash Flow (NASDAQ:ZYME)
      Sep 18Seeking AlphaTBPHZYME
      Theravance Biopharma (TBPH) Presents At Cantor Fitzgerald Global Healthcare Conference - Slideshow (NASDAQ:TBPH-DEFUNCT-155603) 2017-09-27
      Sep 18Seeking AlphaTBPH
      Theravance Biopharma SVP Rhonda Farnum sells $226k in stock
      Sep 17Investing.comTBPH
      Theravance Bio (TBPH) Up 0.8% Since Last Earnings Report: Can It Continue?

      Theravance Bio (TBPH) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

      Sep 9Yahoo FinanceTBPH

      This is the newest page. Registered accounts read further back.